Diversity of heparan sulfate and HSV entry: Basic understanding and treatment strategies

Molecules

Volumn 20, Issue 2, 2015, Pages 2707-2727

  Tiwari, Vaibhav ^a,b   Tarbutton, Morgan S ^a   Shukla, Deepak ^b,c  

^a MIDWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

3 O sulfated heparan sulfate; 3 O sulfotransferase; Herpes simplex virus; Viral entry

Indexed keywords

HEPARAN SULFATE;

ANIMAL; CHEMISTRY; CONFORMATION; HUMAN; KERATITIS, HERPETIC; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIMPLEXVIRUS; STRUCTURE ACTIVITY RELATION; VIRUS ENTRY; ZEBRA FISH;

ANIMALS; CARBOHYDRATE CONFORMATION; HEPARITIN SULFATE; HUMANS; KERATITIS, HERPETIC; SIMPLEXVIRUS; STRUCTURE-ACTIVITY RELATIONSHIP; VIRUS INTERNALIZATION; ZEBRAFISH;

EID: 84928574211     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules20022707     Document Type: Review

References (132)

1. Sarrazin, S.; Lamanna, W.C.; Esko, J.D. Heparan sulfate proteoglycans. Cold Spring Harb. Perspect. Biol. 2011, 3, doi:10.1101/cshperspect.a004952.
2. Nadanaka, S.; Kitagawa, H. Heparan sulphate biosynthesis and disease. J. Biochem. 2008, 144, 7-14, doi:10.1093/jb/mvn040.
3. Bishop, J.R.; Schuksz, M.; Esko, J.D. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 2007, 446, 1030-1037.
4. Esko, J.D.; Lindahl, U. Molecular diversity of heparan sulfate. J. Clin. Investig. 2001, 108, 169-173.
5. Thacker, B.E.; Xu, D.; Lawrence, R.; Esko, J.D. Heparan sulfate 3-O-sulfation: A rare modification in search of a function. Matrix Biol. 2014, 35, 60-72.
6. Shukla, D.; Spear, P.G. Herpesviruses and heparan sulfate: An intimate relationship in aid of viral entry. J. Clin. Investig. 2001, 108, 503-510.
7. Tiwari, V.; Maus, E.; Sigar, I.M.; Ramsey, K.H.; Shukla, D. Role of heparan sulfate in sexually transmitted infections. Glycobiology 2012, 22, 1402-1412.
8. Park, P.J.; Shukla, D. Role of heparan sulfate in ocular diseases. Exp. Eye Res. 2013, 110, 1-9.
9. Lindahl, U.; Kusche-Gullberg, M.; Kjellén, L. Regulated diversity of heparan sulfate. J. Biol. Chem. 1998, 273, 24979-24982.
10. Lindahl, U.; Li, J.P. Interactions between heparan sulfate and proteins-design and functional implications. Int. Rev. Cell Mol. Biol. 2009, 276, 105-159.
11. Kreuger, J.; Jemth, P.; Sanders-Lindberg, E.; Eliahu, L.; Ron, D.; Basilico, C.; Salmivirta, M.; Lindahl, U. Fibroblast growth factors share binding sites in heparan sulphate. Biochem. J. 2005, 389 (Pt 1), 145-150.
12. Kreuger, J.; Spillmann, D.; Li, J.P.; Lindahl, U. Interactions between heparan sulfate and proteins: The concept of specificity. J. Cell Biol. 2006, 174, 323-327.
13. Lembo, D.; Donalisio, M.; Laine, C.; Cagno, V.; Civra, A.; Bianchini, E.P.; Zeghbib, N.; Bouchemal, K. Auto-associative heparin nanoassemblies: A biomimetic platform against the heparan sulfate-dependent viruses HSV-1, HSV-2, HPV-16 and RSV. Eur. J. Pharm. Biopharm. 2014, 88, 275-282.
14. Connell, B.J.; Lortat-Jacob, H. Human immunodeficiency virus and heparan sulfate: From attachment to entry inhibition. Front. Immunol . 2013, 4, 385, doi:10.3389/fimmu.2013.00385.
15. De Francesco, M.A.; Baronio, M.; Poiesi, C. HIV-1 p17 matrix protein interacts with heparan sulfate side chain of CD44v3, syndecan-2, and syndecan-4 proteoglycans expressed on human activated CD4+ T cells affecting tumor necrosis factor alpha and interleukin 2 production. J. Biol. Chem. 2011, 286, 19541-19548.
16. Imamura, J.; Suzuki, Y.; Gonda, K.; Roy, C.N.; Gatanaga, H.; Ohuchi, N.; Higuchi, H. Single particle tracking confirms that multivalent Tat protein transduction domain-induced heparan sulfate proteoglycan cross-linkage activates Rac1 for internalization. J. Biol. Chem. 2011, 286, 10581-10592.
17. Richards, K.F.; Bienkowska-Haba, M.; Dasgupta, J.; Chen, X.S.; Sapp, M. Multiple heparan sulfate binding site engagements are required for the infectious entry of human papillomavirus type 16. J. Virol. 2013, 87, 11426-11437.
18. Lin, C.L.; Chung, C.S.; Heine, H.G.; Chang, W. Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo. J. Virol. 2000, 74, 3353-3365.
19. Tan, C.W.; Poh, C.L.; Sam, I.C.; Chan, Y.F. Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J. Virol. 2013, 87, 611-620.
20. Shi, Q.; Jiang, J.; Luo, G. Syndecan-1 serves as the major receptor for attachment of hepatitis C virus to the surfaces of hepatocytes. J. Virol. 2013, 87, 6866-6875.
21. Dalrymple, N.; Mackow, E.R. Productive dengue virus infection of human endothelial cells is directed by heparan sulfate-containing proteoglycan receptors. J. Virol. 2011, 85, 9478-9485.
22. Silva, L.A.; Khomandiak, S.; Ashbrook, A.W.; Weller, R.; Heise, M.T.; Morrison, T.E.; Dermody, T.S. A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization. J. Virol. 2014, 88, 2385-2397.
23. Koski, A.; Karli, E.; Kipar, A.; Escutenaire, S.; Kanerva, A.; Hemminki, A. Mutation of the fiber shaft heparan sulphate binding site of a 5/3 chimeric adenovirus reduces liver tropism. PLoS One 2013, 8, e60032.
24. Tanaka, A.; Jinno-Oue, A.; Shimizu, N.; Hoque, A.; Mori, T.; Islam, S.; Nakatani, Y.; Shinagawa, M.; Hoshino, H. Entry of human T-cell leukemia virus type 1 is augmented by heparin sulfate proteoglycans bearing short heparin-like structures. J. Virol. 2012, 86, 2959-2969.
25. Morikawa, K.; Zhao, Z.; Date, T.; Miyamoto, M.; Murayama, A.; Akazawa, D.; Tanabe, J.; Sone, S.; Wakita, T. The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles. J. Med. Virol. 2007, 79, 714-723.
26. Immergluck, L.C.; Domowicz, M.S.; Schwartz, N.B.; Herold, B.C. Viral and cellular requirements for entry of herpes simplex virus type 1 into primary neuronal cells. J. Gen. Virol. 1998, 79 (Pt 3), 549-559.
27. Choudhary, S.; Burnham, L.; Thompson, J.M.; Shukla, D.; Tiwari, V. Role of Filopodia in HSV-1 Entry into Zebrafish 3-O-Sulfotransferase-3-Expressing Cells. Open Virol. J. 2013, 7, 41-48.
28. Tiwari, V.; Clement, C.; Xu, D.; Valyi-Nagy, T.; Yue, B.Y.; Liu, J.; Shukla, D. Role for 3-O-sulfated heparan sulfate as the receptor for herpes simplex virus type 1 entry into primary human corneal fibroblasts. J. Virol. 2006, 80, 8970-8980.
29. De Boer, S.M.; Kortekaas, J.; de Haan, C.A.; Rottier, P.J.; Moormann, R.J.; Bosch, B.J. Heparan sulfate facilitates Rift Valley fever virus entry into the cell. J. Virol. 2012, 86, 13767-13771.
30. Tiwari, V.; Liu, J.; Valyi-Nagy, T.; Shukla, D. Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo. J. Biol. Chem. 2011, 286, 25406-25415.
31. Raghuraman, A.; Tiwari, V.; Thakkar, J.N.; Gunnarsson, G.T.; Shukla, D.; Hindle, M.; Desai, U.R. Structural characterization of a serendipitously discovered bioactive macromolecule, lignin sulfate. Biomacromolecules 2005, 6, 2822-2832.
32. Raghuraman, A.; Tiwari, V.; Zhao, Q.; Shukla, D.; Debnath, A.K.; Desai, U.R. Viral inhibition studies on sulfated lignin, a chemically modified biopolymer and a potential mimic of heparan sulfate. Biomacromolecules 2007, 8, 1759-1763.
33. Thakkar, J.N.; Tiwari, V.; Desai, U.R. Nonsulfated, cinnamic acid-based lignins are potent antagonists of HSV-1 entry into cells. Biomacromolecules 2010, 11, 1412-1416.
34. Nyberg, K.; Ekblad, M.; Bergström, T.; Freeman, C.; Parish, C.R.; Ferro, V.; Trybala, E. The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus. Antivir. Res. 2004, 63, 15-24.
35. Damonte, E.B.; Matulewicz, M.C.; Cerezo, A.S. Sulfated seaweed polysaccharides as antiviral agents. Curr. Med. Chem. 2004, 11, 2399-2419.
36. Copeland, R.; Balasubramaniam, A.; Tiwari, V.; Zhang, F.; Bridges, A.; Linhardt, R.J.; Shukla, D.; Liu, J. Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1. Biochemistry 2008, 47, 5774-5783.
37. Ceballos, A.; Remes Lenicov, F.; Sabatté, J.; Rodríguez Rodrígues, C.; Cabrini, M.; Jancic, C.; Raiden, S.; Donaldson, M.; Agustín Pasqualini, R., Jr.; Marin-Briggiler, C.; et al. Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells. J. Exp. Med. 2009, 206, 2717-2733.
38. De Witte, L.; Zoughlami, Y.; Aengeneyndt, B.; David, G.; van Kooyk, Y.; Gissmann, L.; Geijtenbeek, T.B. Binding of human papilloma virus L1 virus-like particles to dendritic cells is mediated through heparan sulfates and induces immune activation. Immunobiology 2007, 212, 679-691.
39. Shukla, D.; Liu, J.; Blaiklock, P.; Shworak, N.W.; Bai, X.; Esko, J.D.; Cohen, G.H.; Eisenberg, R.J.; Rosenberg, R.D.; Spear, P.G. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 1999, 99, 13-22.
40. Lawrence, R.; Yabe, T.; Hajmohammadi, S.; Rhodes, J.; McNeely, M.; Liu, J.; Lamperti, E.D.; Toselli, P.A.; Lech, M.; Spear, P.G.; et al. The principal neuronal gD-type 3-O-sulfotransferases and their products in central and peripheral nervous system tissues. Matrix Biol. 2007, 26, 442-455.
41. O'Donnell, C.D.; Kovacs, M.; Akhtar, J.; Valyi-Nagy, T.; Shukla, D. Expanding the role of 3-O sulfated heparan sulfate in herpes simplex virus type-1 entry. Virology 2010, 397, 389-398.
42. Tiwari, V.; ten Dam, G.B.; Yue, B.Y.; van Kuppevelt, T.H.; Shukla, D. Role of 3-O-sulfated heparan sulfate in virus-induced polykaryocyte formation. FEBS Lett. 2007, 581, 4468-4472.
43. Spear, P.G. Herpes simplex virus: Receptors and ligands for cell entry. Cell. Microbiol. 2004, 6, 401-410.
44. Spear, P.G.; Longnecker, R. Herpesvirus entry: An update. J. Virol. 2003, 77, 10179-10185.
45. Akhtar, J.; Shukla, D. Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry. FEBS J. 2009, 276, 7228-7236.
46. Zhang, Z.; Liu, X.; Chen, J.; Su, H.; Luo, Q.; Ye, J.; Tang, N.; Zhang, W.; Chen, W.; Ko, B.C.; et al. Heparin sulphate D-glucosaminyl 3-O-sulfotransferase 3B1 plays a role in HBV replication. Virology 2010, 406, 280-285.
47. Borst, E.M.; Ständker, L.; Wagner, K.; Schulz, T.F.; Forssmann, W.G.; Messerle, M. A peptide inhibitor of cytomegalovirus infection from human hemofiltrate. Antimicrob. Agents Chemother. 2013, 57, 4751-4760.
48. Baldwin, J.; Shukla, D.; Tiwari, V. Members of 3-O-Sulfotransferases (3-OST) Family: A Valuable Tool from Zebrafish to Humans for Understanding Herpes Simplex Virus Entry. Open Virol. J. 2013, 7, 5-11.
49. Hubbard, S.; Darmani, N.A.; Thrush, G.R.; Dey, D.; Burnham, L.; Thompson, J.M.; Jones, K.; Tiwari, V. Zebrafish-encoded 3-O-sulfotransferase-3 isoform mediates herpes simplex virus type 1 entry and spread. Zebrafish 2010, 7, 181-187.
50. Yakoub, A.M.; Rawal, N.; Maus, E.; Baldwin, J.; Shukla, D.; Tiwari, V. Comprehensive analysis of herpes simplex virus 1 (HSV-1) entry mediated by zebrafish 3-O-Sulfotransferase isoforms: implications for the development of a zebrafish model of HSV-1 infection. J. Virol. 2014, 88, 12915-12922.
51. Norose, K.; Yano, A.; Zhang, X.M.; Blankenhorn, E.; Heber-Katz, E. Mapping of genes involved in murine herpes simplex virus keratitis: identification of genes and their modifiers. J. Virol. 2002, 76, 3502-3510.
52. Zautner, A.E.; Jahn, B.; Hammerschmidt, E.; Wutzler, P.; Schmidtke, M. N- and 6- O-sulfated heparan sulfates mediate internalization of coxsackievirus B3 variant PD into CHO-K1 cells. J. Virol. 2006, 80, 629-636.
53. Makkonen, K.E.; Turkki, P.; Laakkonen, J.P.; Ylä-Herttuala, S.; Marjomäki, V.; Airenne, K.J. 6-O- and N-sulfated syndecan-1 promotes baculovirus binding and entry into Mammalian cells. J. Virol. 2013, 87, 11148-11159.
54. Kobayashi, F.; Yamada, S.; Taguwa, S.; Kataoka, C.; Naito, S.; Hama, Y.; Tani, H.; Matsuura, Y.; Sugahara, K. Specific interaction of the envelope glycoproteins E1 and E2 with liver heparan sulfate involved in the tissue tropismatic infection by hepatitis C virus. Glycoconj. J. 2012, 29, 211-220.
55. Matos, P.M.; Andreu, D.; Santos, N.C.; Gutiérrez-Gallego, R. Structural requirements of glycosaminoglycans for their interaction with HIV-1 envelope glycoprotein gp120. Arch. Virol. 2014, 159, 555-560.
56. Rider, C.C.; Coombe, D.R.; Harrop, H.A.; Hounsell, E.F.; Bauer, C.; Feeney, J.; Mulloy, B.; Mahmood, N.; Hay, A.; Parish, C.R. Anti-HIV-1 activity of chemically modified heparins: Correlation between binding to the V3 loop of gp120 and inhibition of cellular HIV-1 infection in vitro. Biochemistry 1994, 33, 6974-6980.
57. Trybala, E.; Bergström, T.; Spillmann, D.; Svennerholm, B.; Olofsson, S.; Flynn, S.J.; Ryan, P. Mode of interaction between pseudorabies virus and heparan sulfate/heparin. Virology 1996, 218, 35-42.
58. Trybala, E.; Liljeqvist, J.A.; Svennerholm, B.; Bergström, T. Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate. J. Virol. 2000, 74, 9106-9114.
59. Seki, Y.; Mizukura, M.; Ichimiya, T.; Suda, Y.; Nishihara, S.; Masuda, M.; Takase-Yoden, S. O-sulfate groups of heparin are critical for inhibition of ecotropic murine leukemia virus infection by heparin. Virology 2012, 424, 56-66.
60. Hallak, L.K.; Spillmann, D.; Collins, P.L.; Peeples, M.E. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J. Virol. 2000, 74, 10508-10513.
61. Oh, M.J.; Akhtar, J.; Desai, P.; Shukla, D. A role for heparan sulfate in viral surfing. Biochem. Biophys. Res. Commun. 2010, 391, 176-181.
62. Liu, J.; Shworak, N.W.; Sinaÿ, P.; Schwartz, J.J.; Zhang, L.; Fritze, L.M.; Rosenberg, R.D. Expression of heparan sulfate D-glucosaminyl 3-O-sulfotransferase isoforms reveals novel substrate specificities. J. Biol. Chem. 1999, 274, 5185-5192.
63. Xia, G.; Chen, J.; Tiwari, V.; Ju, W.; Li, J.P.; Malmstrom, A.; Shukla, D.; Liu, J. Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1. J. Biol. Chem. 2002, 277, 37912-37919.
64. Xu, D.; Tiwari, V.; Xia, G.; Clement, C.; Shukla, D.; Liu, J. Characterization of heparan sulphate 3-O-sulphotransferase isoform 6 and its role in assisting the entry of herpes simplex virus type 1. Biochem. J. 2005, 385 (Pt 2), 451-459.
65. O'Donnell, C.D.; Tiwari, V.; Oh, M.J.; Shukla, D. A role for heparan sulfate 3-O-sulfotransferase isoform 2 in herpes simplex virus type 1 entry and spread. Virology 2006, 346, 452-459.
66. Tiwari, V.; O'Donnell, C.D.; Oh, M.J.; Valyi-Nagy, T.; Shukla, D. A role for 3-O-sulfotransferase isoform-4 in assisting HSV-1 entry and spread. Biochem. Biophys. Res. Commun. 2005, 338, 930-937.
67. Shworak, N.W.; Liu, J.; Petros, L.M.; Zhang, L.; Kobayashi, M.; Copeland, N.G.; Jenkins, N.A.; Rosenberg, R.D. Multiple isoforms of heparan sulfate D-glucosaminyl 3- O-sulfotransferase. Isolation, characterization, and expression of human cdnas and identification of distinct genomic loci. J. Biol. Chem. 1999, 274, 5170-5184.
68. Mochizuki, H.; Yoshida, K.; Gotoh, M.; Sugioka, S.; Kikuchi, N.; Kwon, Y.D.; Tawada, A.; Maeyama, K.; Inaba, N.; Hiruma, T.; et al. Characterization of a heparan sulfate 3-O-sulfotransferase-5, an enzyme synthesizing a tetrasulfated disaccharide. J. Biol. Chem. 2003, 278, 26780-26787.
69. Yabe, T.; Hata, T.; He, J.; Maeda, N. Developmental and regional expression of heparan sulfate sulfotransferase genes in the mouse brain. Glycobiology 2005, 15, 982-993.
70. Zhang, X.; Wang, B.; Li, J.P. Implications of heparan sulfate and heparanase in neuroinflammation. Matrix Biol. 2014, 35, 174-181.
71. Yabe, T.; Maeda, N. Histochemical analysis of heparan sulfate 3-O-sulfotransferase expression in mouse brain. Methods Mol. Biol. 2015, 1229, 377-387.
72. Park, P.J.; Chang, M.; Garg, N.; Zhu, J.; Chang, J.H.; Shukla, D. Corneal lymphangiogenesis in herpetic stromal keratitis. Surv. Ophthalmol. 2015, 60, 60-71.
73. Banerjee, K.; Biswas, P.S.; Kumaraguru, U.; Schoenberger, S.P.; Rouse, B.T. Protective and pathological roles of virus-specific and bystander CD8+ T cells in herpetic stromal keratitis. J. Immunol. 2004, 173, 7575-7583.
74. Shen, F.H.; Wang, S.W.; Yeh, T.M.; Tung, Y.Y.; Hsu, S.M.; Chen, S.H. Absence of CXCL10 aggravates herpes stromal keratitis with reduced primary neutrophil influx in mice. J. Virol. 2013, 87, 8502-8510.
75. Giménez, F.; Suryawanshi, A.; Rouse, B.T. Pathogenesis of herpes stromal keratitis - A focus on corneal neovascularization. Prog. Retin. Eye Res. 2013, 33, 1-9.
76. Rolinski, J.; Hus, I. Immunological aspects of acute and recurrent herpes simplex keratitis. J. Immunol. Res. 2014, 2014, 513560, doi:10.1155/2014/513560.
77. Van Wijk, X.M.; van Kuppevelt, T.H. Heparan sulfate in angiogenesis: A target for therapy. Angiogenesis 2014, 17, 443-462.
78. Iozzo, R.V.; san Antonio, J.D. Heparan sulfate proteoglycans: Heavy hitters in the angiogenesis arena. J. Clin. Investig. 2001, 108, 349-355.
79. Xu, D.; Fuster, M.M.; Lawrence, R.; Esko, J.D. Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability. J. Biol. Chem. 2011, 286, 737-745, doi:10.1074/jbc.M110.177006.
80. Robinson, C.J.; Mulloy, B.; Gallagher, J.T.; Stringer, S.E. VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase. J. Biol. Chem. 2006, 281, 1731-1740.
81. Maccarana, M.; Casu, B.; Lindahl, U. Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J. Biol. Chem. 1993, 268, 23898-23905.
82. Guimond, S.; Maccarana, M.; Olwin, B.B.; Lindahl, U.; Rapraeger, A.C. Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. J. Biol. Chem. 1993, 268, 23906-23914.
83. Suryawanshi, A.; Veiga-Parga, T.; Reddy, P.B.; Rajasagi, N.K.; Rouse, B.T. IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection. J. Immunol. 2012, 188, 3434-3446.
84. Young, R.D.; Knupp, C.; Pinali, C.; Png, K.M.; Ralphs, J.R.; Bushby, A.J.; Starborg, T.; Kadler, K.E.; Quantock, A.J. Three-dimensional aspects of matrix assembly by cells in the developing cornea. Proc. Natl. Acad. Sci. USA 2014, 111, 687-692.
85. Clement, C.; Tiwari, V.; Scanlan, P.M.; Valyi-Nagy, T.; Yue, B.Y.; Shukla, D. A novel role for phagocytosis-like uptake in herpes simplex virus entry. J. Cell Biol. 2006, 174, 1009-1021.
86. Tiwari, V.; Shukla, D. Nonprofessional phagocytosis can facilitate herpesvirus entry into ocular cells. Clin. Dev. Immunol. 2012, 2012, 651691, doi:10.1155/2012/651691.
87. Antoine, T.E.; Jones, K.S.; Dale, R.M.; Shukla, D.; Tiwari, V. Zebrafish: Modeling for herpes simplex virus infections. Zebrafish 2014, 11, 17-25.
88. Meijer, A.H.; Spaink, H.P. Host-pathogen interactions made transparent with the zebrafish model. Curr. Drug Targets 2011, 12, 1000-1017.
89. Van der Sar, A.M.; Appelmelk, B.J.; Vandenbroucke-Grauls, C.M.; Bitter, W. A star with stripes: Zebrafish as an infection model. Trends Microbiol. 2004, 12, 451-457.
90. Wilkinson, R.N.; van Eeden, F.J. The zebrafish as a model of vascular development and disease. Prog. Mol. Biol. Transl. Sci. 2014, 124, 93-122.
91. Cadwallader, A.B.; Yost, H.J. Combinatorial expression patterns of heparan sulfate sulfotransferases in zebrafish: I. The 3-O-sulfotransferase family. Dev. Dyn. 2006, 235, 3423-3431.
92. Samson, S.C.; Ferrer, T.; Jou, C.J.; Sachse, F.B.; Shankaran, S.S.; Shaw, R.M.; Chi, N.C.; Tristani-Firouzi, M.; Yost, H.J. 3-OST-7 regulates BMP-dependent cardiac contraction. PLoS Biol. 2013, 11, e1001727.
93. Gabor, K.A.; Goody, M.F.; Mowel, W.K.; Breitbach, M.E.; Gratacap, R.L.; Witten, P.E.; Kim, C.H. Influenza A virus infection in zebrafish recapitulates mammalian infection and sensitivity to anti-influenza drug treatment. Dis. Model. Mech. 2014, 7, 1227-1237.
94. Heur, M.; Jiao, S.; Schindler, S.; Crump, J.G. Regenerative potential of the zebrafish corneal endothelium. Exp. Eye Res. 2013, 106, 1-4.
95. Whiteford, J.R.; Ko, S.; Lee, W.; Couchman, J.R. Structural and cell adhesion properties of zebrafish syndecan-4 are shared with higher vertebrates. J. Biol. Chem. 2008, 283, 29322-29330.
96. Baldwin, J.; Antoine, T.E.; Shukla, D.; Tiwari, V. Zebrafish encoded 3-O-sulfotransferase-2 generated heparan sulfate serves as a receptor during HSV-1 entry and spread. Biochem. Biophys. Res. Commun. 2013, 432, 672-676.
97. Antoine, T.E.; Yakoub, A.; Maus, E.; Shukla, D.; Tiwari, V. Zebrafish 3-O-sulfotransferase-4 generated heparan sulfate mediates HSV-1 entry and spread. PLoS One 2014, 9, e87302.
98. Burgos, J.S.; Ripoll-Gomez, J.; Alfaro, J.M.; Sastre, I.; Valdivieso, F. Zebrafish as a new model for herpes simplex virus type 1 infection. Zebrafish 2008, 5, 323-333, doi:10.1089/zeb.2008.0552.
99. Salameh, S.; Sheth, U.; Shukla, D. Early events in herpes simplex virus lifecycle with implications for an infection of lifetime. Open Virol. J. 2012, 6, 1-6.
100. Karasneh, G.A.; Shukla, D. Herpes simplex virus infects most cell types in vitro: Clues to its success. Virol. J. 2011, 8, 481. Available online: http://www.biomedcentral.com/content/pdf/1743-422X-8-481.pdf (accessed on 3 February 2015).
101. Esko, J.D.; Selleck, S.B. Order out of chaos: Assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem. 2002, 71, 435-471.
102. Presto, J.; Thuveson, M.; Carlsson, P.; Busse, M.; Wilén, M.; Eriksson, I.; Kusche-Gullberg, M.; Kjellén, L. Heparan sulfate biosynthesis enzymes EXT1 and EXT2 affect NDST1 expression and heparan sulfate sulfation. Proc. Natl. Acad. Sci. USA 2008, 105, 4751-4756.
103. Ekblad, M.; Adamiak, B.; Bergstrom, T.; Johnstone, K.D.; Karoli, T.; Liu, L.; Ferro, V.; Trybala, E. A highly lipophilic sulfated tetrasaccharide glycoside related to muparfostat (PI-88) exhibits virucidal activity against herpes simplex virus. Antivir. Res. 2010, 86, 196-203.
104. Ekblad, M.; Bergström, T.; Banwell, M.G.; Bonnet, M.; Renner, J.; Ferro, V.; Trybala, E. Anti-herpes simplex virus activities of two novel disulphated cyclitols. Antivir. Chem. Chemother. 2006, 17, 97-106.
105. Ferro, V.; Liu, L.; Johnstone, K.D.; Wimmer, N.; Karoli, T.; Handley, P.; Rowley, J.; Dredge, K.; Li, C.P.; Hammond, E.; et al. Discovery of PG545: A highly potent and simultaneous inhibitor of angiogenesis, tumor growth, and metastasis. J. Med. Chem. 2012, 55, 3804-3813.
106. Said, J.; Trybala, E.; Andersson, E.; Johnstone, K.; Liu, L.; Wimmer, N.; Ferro, V.; Bergström, T. Lipophile-conjugated sulfated oligosaccharides as novel microbicides against HIV-1. Antivir. Res. 2010, 86, 286-295.
107. Lundin, A.; Bergström, T.; Andrighetti-Fröhner, C.R.; Bendrioua, L.; Ferro, V.; Trybala, E. Potent anti-respiratory syncytial virus activity of a cholestanol-sulfated tetrasaccharide conjugate. Antivir. Res. 2012, 93, 101-109.
108. Gandhi, N.S.; Mancera, R.L. Heparin/heparan sulphate-based drugs. Drug Discov. Today 2010, 15, 1058-1069.
109. Khachigian, L.M.; Parish, C.R. Phosphomannopentaose sulfate (PI-88): Heparan sulfate mimetic with clinical potential in multiple vascular pathologies. Cardiovasc. Drug Rev. 2004, 22, 1-6.
110. Knelson, E.H.; Nee, J.C.; Blobe, G.C. Heparan sulfate signaling in cancer. Trends Biochem. Sci. 2014, 39, 277-288.
111. Ferro, V. Heparan sulfate inhibitors and their therapeutic implications in inflammatory illnesses. Expert Opin. Ther. Targets 2013, 17, 965-975.
112. Ferro, V.; Dredge, K.; Liu, L.; Hammond, E.; Bytheway, I.; Li, C.; Johnstone, K.; Karoli, T.; Davis, K.; Copeman, E.; et al . PI-88 and novel heparan sulfate mimetics inhibit angiogenesis. Semin. Thromb. Hemost. 2007, 33, 557-568.
113. Lindahl, U.; Kjellén, L. Pathophysiology of heparan sulphate: many diseases, few drugs. J. Intern. Med. 2013, 273, 555-571.
114. Ali, M.M.; Karasneh, G.A.; Jarding, M.J.; Tiwari, V.; Shukla, D. A 3-O-sulfated heparan sulfate binding peptide preferentially targets herpes simplex virus 2-infected cells. J. Virol. 2012, 86, 6434-6443.
115. Luganini, A.; Nicoletto, S.F.; Pizzuto, L.; Pirri, G.; Giuliani, A.; Landolfo, S.; Gribaudo, G. Inhibition of herpes simplex virus type 1 and type 2 infections by peptide-derivatized dendrimers. Antimicrob. Agents Chemother. 2011, 55, 3231-3239.
116. Connell, B.J.; Baleux, F.; Coic, Y.M.; Clayette, P.; Bonnaffé, D.; Lortat-Jacob, H. A synthetic heparan sulfate-mimetic peptide conjugated to a mini CD4 displays very high anti-HIV-1 activity independently of coreceptor usage. Chem. Biol. 2012, 19, 131-139.
117. Baleux, F.; Loureiro-Morais, L.; Hersant, Y.; Clayette, P.; Arenzana-Seisdedos, F.; Bonnaffé, D.; Lortat-Jacob, H. A synthetic CD4-heparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entry. Nat. Chem. Biol. 2009, 5, 743-748.
118. Bacsa, S.; Karasneh, G.; Dosa, S.; Liu, J.; Valyi-Nagy, T.; Shukla, D. Syndecan-1 and syndecan-2 play key roles in herpes simplex virus type-1 infection. J. Gen. Virol. 2011, 92 (Pt 4), 733-743.
119. Karasneh, G.A.; Ali, M.; Shukla, D. An important role for syndecan-1 in herpes simplex virus type-1 induced cell-to-cell fusion and virus spread. PLoS One 2011, 6, e25252.
120. Lortat-Jacob, H. The molecular basis and functional implications of chemokine interactions with heparan sulphate. Curr. Opin. Struct. Biol. 2009, 19, 543-548.
121. Parish, C.R. The role of heparan sulphate in inflammation. Nat. Rev. Immunol. 2006, 6, 633-643.
122. Götte, M. Syndecans in inflammation. FASEB J. 2003, 17, 575-591.
123. Webb, L.M.; Ehrengruber, M.U.; Clark-Lewis, I.; Baggiolini, M.; Rot, A. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc. Natl. Acad. Sci. USA 1993, 90, 7158-7162.
124. Duan, R.; Remeijer, L.; van Dun, J.M.; Osterhaus, A.D.; Verjans, G.M. Granulocyte macrophage colony-stimulating factor expression in human herpetic stromal keratitis: Implications for the role of neutrophils in HSK. Investig. Ophthalmol. Vis. Sci. 2007, 48, 277-284.
125. Turnbull, J.E.; Miller, R.L.; Ahmed, Y.; Puvirajesinghe, T.M.; Guimond, S.E. Glycomics profiling of heparan sulfate structure and activity. Methods Enzymol. 2010, 480, 65-85.
126. Taylor, K.R.; Gallo, R.L. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J. 2006, 20, 9-22.
127. Stringer, S.E. The role of heparan sulphate proteoglycans in angiogenesis. Biochem. Soc. Trans. 2006, 34 (Pt 3), 451-453.
128. Adamiak, B.; Ekblad, M.; Bergström, T.; Ferro, V.; Trybala, E. Herpes simplex virus type 2 glycoprotein G is targeted by the sulfated oligo- and polysaccharide inhibitors of virus attachment to cells. J. Virol. 2007, 81, 13424-13434.
129. Tuve, S.; Wang, H.; Jacobs, J.D.; Yumul, R.C.; Smith, D.F.; Lieber, A. Role of cellular heparan sulfate proteoglycans in infection of human adenovirus serotype 3 and 35. PLoS Pathog. 2008, 4, e1000189.
130. Dong, L.Q.; Wang, X.Q.; Guo, Y.N.; Wu, J.; Li, S.; Yu, P.; Wang, Z. HS N-sulfation and iduronic acids play an important role in the infection of respiratory syncytial virus in vitro. Eur. Rev. Med. Pharmacol. Sci. 2013, 17, 1864-1868.
131. Schowalter, R.M.; Pastrana, D.V.; Buck, C.B. Glycosaminoglycans and sialylated glycans sequentially facilitate Merkel cell polyomavirus infectious entry. PLoS Pathog. 2011, 7, e1002161.
132. Liu, J.; Thorp, S.C. Cell surface heparan sulfate and its roles in assisting viral infections. Med. Res. Rev. 2002, 22, 1-25.